Fig. 4From: A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancerThe doses and schedules of the neoadjuvant chemotherapy combined neoadjuvant immunotherapyBack to article page